Insider · CIK 0001309653
Mohammad Azab
director
Files at LSTA (LISATA THERAPEUTICS, INC.), DRRX (DURECT CORP). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | DRRX DURECT CORP | UTender of shares Common Stock | -6,000 | - | - | 0 | Sep 12, 2025 |
| Sep 11, 2025 | DRRX DURECT CORP | DDisposition to issuer Stock Option (right to buy)derivative | -7,000 | - | - | 0 | Sep 12, 2025 |
| Sep 11, 2025 | DRRX DURECT CORP | DDisposition to issuer Stock Option (right to buy)derivative | -2,750 | - | - | 0 | Sep 12, 2025 |
| Sep 11, 2025 | DRRX DURECT CORP | DDisposition to issuer Stock Option (right to buy)derivative | -5,500 | - | - | 0 | Sep 12, 2025 |
| Sep 11, 2025 | DRRX DURECT CORP | DDisposition to issuer Stock Option (right to buy)derivative | -5,500 | - | - | 0 | Sep 12, 2025 |
| Sep 11, 2025 | DRRX DURECT CORP | DDisposition to issuer Stock Option (right to buy)derivative | -5,500 | - | - | 0 | Sep 12, 2025 |
| Jan 9, 2025 | LSTA LISATA THERAPEUTICS, INC. | AGrant or award Common Stock | +15,789 | $0.00 | $0 | 74,469 | Jan 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.